Meiji Seika Pharma

Meiji Seika Pharma is a pharmaceutical company founded in 1931 in Japan. The company focuses on the research, development, and commercialization of pharmaceutical products with a particular emphasis on treatments for neurological disorders, infectious diseases, and metabolic diseases. Their portfolio includes drugs for the treatment of conditions such as diabetes, Alzheimer's disease, and various infectious diseases. Meiji Seika Pharma is committed to advancing scientific knowledge and improving healthcare outcomes through its innovative drug therapies.